Literature DB >> 30259362

Circular RNAs in Blood.

Angela Vea1, Vicenta Llorente-Cortes1,2,3, David de Gonzalo-Calvo4,5,6.   

Abstract

Recent advances in RNA sequencing and bioinformatic analysis have allowed the development of a new research field: circular RNAs (circRNAs). These members of the non-coding transcriptome are generated by backsplicing, which results in a covalently closed, single-stranded RNA molecule. To date, thousands of circRNAs have been identified in different human cell types. CircRNAs are evolutionarily conserved, highly stable, cell-/developmental stage-specific and have longer half-lives compared with linear RNAs. Interestingly, different studies have demonstrated that circRNAs are abundantly expressed in the bloodstream. In this chapter, we review the current knowledge of circRNA biology in blood cells and the cell-free compartment, including extracellular vesicles. The potential clinical application of blood circRNAs in the biomarker and therapy fields is also discussed. Finally, perspectives for future studies are proposed.

Entities:  

Keywords:  Blood; Circular RNA; Extracellular vesicles; Plasma; Serum

Mesh:

Substances:

Year:  2018        PMID: 30259362     DOI: 10.1007/978-981-13-1426-1_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

Review 1.  CircRNAs and their regulatory roles in cancers.

Authors:  Mei Tao; Ming Zheng; Yanhua Xu; Shuo Ma; Weiwei Zhang; Shaoqing Ju
Journal:  Mol Med       Date:  2021-08-26       Impact factor: 6.354

2.  Early pregnancy prediction of spontaneous preterm birth before 32 completed weeks of pregnancy using plasma RNA: transcriptome discovery and initial validation of an RNA panel of markers.

Authors:  C P Weiner; Y Dong; H Zhou; H Cuckle; R Ramsey; R Egerman; I Buhimschi; C Buhimschi
Journal:  BJOG       Date:  2021-05-27       Impact factor: 7.331

3.  Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer.

Authors:  Wei Wang; Jinshu Wang; Xinzhong Zhang; Gang Liu
Journal:  Onco Targets Ther       Date:  2019-09-11       Impact factor: 4.147

4.  Circ-IGF1R inhibits cell invasion and migration in non-small cell lung cancer.

Authors:  Zhanyu Xu; Weiwei Xiang; Wenjie Chen; Yu Sun; Fanglu Qin; Jiangbo Wei; Liqiang Yuan; Liping Zheng; Shikang Li
Journal:  Thorac Cancer       Date:  2020-02-27       Impact factor: 3.500

5.  Circular RNA circNRIP1 promotes migration and invasion in cervical cancer by sponging miR-629-3p and regulating the PTP4A1/ERK1/2 pathway.

Authors:  Xinhui Li; Ningye Ma; Yao Zhang; Heng Wei; Huijie Zhang; Xiaoao Pang; Xiang Li; Dan Wu; Dian Wang; Zhuo Yang; Shulan Zhang
Journal:  Cell Death Dis       Date:  2020-05-26       Impact factor: 8.469

Review 6.  The Roles of Host Noncoding RNAs in Mycobacterium tuberculosis Infection.

Authors:  Li Wei; Kai Liu; Qingzhi Jia; Hui Zhang; Qingli Bie; Bin Zhang
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

Review 7.  Circular RNAs: Novel Players in the Oxidative Stress-Mediated Pathologies, Biomarkers, and Therapeutic Targets.

Authors:  Yunguang Wang; Wenfang He; Sherif A Ibrahim; Qiang He; Juan Jin
Journal:  Oxid Med Cell Longev       Date:  2021-06-23       Impact factor: 6.543

8.  Circ_0006332 promotes growth and progression of bladder cancer by modulating MYBL2 expression via miR-143.

Authors:  Mingshan Li; Yili Liu; Jie Liu; Wei Li; Ning Li; Dongwei Xue; Xiling Zhang; Ping Wang
Journal:  Aging (Albany NY)       Date:  2019-11-22       Impact factor: 5.682

Review 9.  Circular RNAs in renal cell carcinoma: implications for tumorigenesis, diagnosis, and therapy.

Authors:  Ying Wang; Yunjing Zhang; Ping Wang; Xianghui Fu; Weiqiang Lin
Journal:  Mol Cancer       Date:  2020-10-14       Impact factor: 27.401

Review 10.  The Roles of CircRNAs in Bladder Cancer: Biomarkers, Tumorigenesis Drivers, and Therapeutic Targets.

Authors:  Fajuan Cheng; Bin Zheng; Shubin Si; Jianwei Wang; Guiting Zhao; Zhongshun Yao; Zhihong Niu; Wei He
Journal:  Front Cell Dev Biol       Date:  2021-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.